瀛通通讯(002861) - 2025 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2025 was ¥164,238,455.53, representing a slight increase of 1.42% compared to ¥161,946,180.25 in the same period last year[5] - The net loss attributable to shareholders was ¥17,444,881.82, a significant increase of 117.30% from a loss of ¥8,027,844.04 in the previous year[5] - The net cash flow from operating activities was negative at ¥8,985,487.20, slightly worse than the previous year's negative cash flow of ¥8,692,991.36, reflecting a decline of 3.36%[5] - Total operating revenue for the current period was ¥164,238,455.53, an increase of 1.8% compared to ¥161,946,180.25 in the previous period[24] - Net profit for the current period was a loss of ¥17,444,881.82, compared to a loss of ¥8,027,844.04 in the previous period[25] - The company reported a comprehensive loss of ¥17,787,100.45, compared to a loss of ¥8,942,405.12 in the previous period[26] - Basic and diluted earnings per share were both -0.09, compared to -0.05 in the previous period[26] Assets and Liabilities - The company's total assets decreased by 4.31% to ¥1,583,013,807.60 from ¥1,654,343,042.44 at the end of the previous year[5] - The total current assets amount to 579,948,069.48 RMB, a decrease from 666,803,337.48 RMB at the beginning of the period, reflecting a decline of approximately 13.00%[21] - The total non-current assets are valued at 1,003,065,738.12 RMB, showing an increase from 987,539,704.96 RMB, representing a growth of about 1.55%[21] - Total liabilities decreased to ¥439,626,127.87 from ¥493,168,262.26, reflecting a reduction of approximately 10.9%[22] - Total current liabilities are 285,693,266.89 RMB, down from 340,358,971.50 RMB, reflecting a reduction of about 16.06%[21] - The company has a long-term loan of 130,720,150.88 RMB, which increased from 128,640,000.00 RMB, indicating a rise of approximately 0.84%[21] Cash Flow - The net cash flow from investment activities was positive at $40.45 million, a significant improvement from a negative $50.20 million in the previous period[28] - Cash inflow from investment activities totaled $232.71 million, while cash outflow was $192.27 million, indicating a healthy investment environment[28] - Cash flow from financing activities showed a net outflow of $1.46 million, compared to a net inflow of $10.14 million previously, reflecting changes in financing strategy[28] - The company reported a net increase in cash and cash equivalents of $30.82 million, contrasting with a decrease of $47.96 million in the prior period[28] - The ending balance of cash and cash equivalents stood at $114.37 million, up from $91.75 million at the end of the previous period[28] - Cash received from investment income was $935,081.07, while cash received from other investment-related activities was $231.78 million[28] - Total cash inflow from financing activities was $3.06 million, primarily from borrowings[28] - Cash paid for debt repayment was $3 million, indicating a focus on managing liabilities[28] - The impact of exchange rate fluctuations on cash and cash equivalents was positive, contributing $818,869.47[28] Shareholder Information - The total number of common shareholders at the end of the reporting period is 39,176, with the top 10 shareholders holding a combined 47.58% of shares[17] - Huang Hui is the largest shareholder, holding 24.00% of shares, amounting to 44,712,670 shares, with 10,500,000 shares pledged[17] - The top 10 shareholders do not participate in margin financing or securities lending activities[18] - The company has no preferred shareholders as indicated in the report[18] Expenses and Profitability - The gross profit margin decreased due to new projects still ramping up production efficiency, impacting profitability[9] - Selling expenses increased by 46.05% to ¥7,607,192.36, primarily due to increased brand promotion costs for the health segment[13] - Research and development expenses were ¥10,389,656.92, slightly down from ¥10,594,480.07 in the previous period[24] Strategic Focus - The company plans to enhance its core competitiveness through increased investment in brand promotion and channel development in the health sector[9] - The company is focusing on expanding its product line into noise-reducing home appliances, which are expected to provide new revenue growth points despite lower margins compared to traditional acoustic products[9] Audit Status - The first quarter report was not audited, which may affect the perception of financial reliability[29]